Prenylamine Induced Prolonged QT Syndrome and Ventricular Tachycardia
DOI:
https://doi.org/10.47144/phj.v14i4.482Keywords:
Prenylamine Induced Prolonged QT Syndrome and Ventricular TachycardiaAbstract
INTRODUCTION:
Prenylamine a calcium antagonist is a widely used anti-angina! drug and is generally considered safe.1 Indeed very few life threatening arrhythmias have been reported with its use. 2-3 Thus the association of ventricular arrhythmias with 1)renylamine is of special interest, especially in view of the fact that it can be anticipated and thus avoided. We shall discuss the presentation and mode of treatment of two cases with prolonged QT intervals and serious symptomatic ventricular tachycardia caused by Prenylamine.
DISCUSSION:
Prenylaminc prolongs the QT interval owing to its quinidine like properties. The long rep olarisation time favours a state of asynchronous depolarization ad may lead to reentrant arrhy.t hmias.1 Ventricular tachycardia may display the features of torsade de polrtes4 in form of late diastolic ventricular premature beat, undulating QRS axis and prolonged QT interval as seen in the first case. The arrhythmia may progress to fatal ventricular fibrillation in some cases specially if its character is not recognised. We advocate routine electrocardiographic checkup in patients on prenylamine. Particular attention must be paid to prolongation of the QT interval, which may be the harbingir of life threatening ventricular arrhythmias.
Downloads
Downloads
How to Cite
Issue
Section
License
When an article is accepted for publication in the print format, the author will be required to transfer exclusive copyright to the PHJ and retain the rights to use and share their published article with others. However, re-submission of the full article or any part for publication by a third party would require prior permission of the PHJ.
Online publication will allow the author to retain the copyright and share the article under the agreement described in the licensing rights with creative commons, with appropriate attribution to PHJ. Creative Commons attribution license CC BY 4.0 is applied to articles published in PHJ https://creativecommons.org/licenses/by/4.0/